Bone remodelation markers are useful in the management of monoclonal gammopathies.

@article{Hernndez2004BoneRM,
  title={Bone remodelation markers are useful in the management of monoclonal gammopathies.},
  author={Jos{\'e} Mariano Hern{\'a}ndez and Bego{\~n}a Suqu{\'i}a and Jos{\'e} Antonio Queiz{\'a}n and Rosa Mar{\'i}a Fisac and Jos{\'e} Javier Aguirre S{\'a}nchez and Francisco J Fern{\'a}ndez-Calvo and Ram{\'o}n Garc{\'i}a-Sanz and Carmen Olivier and Abelardo B{\'a}rez and Mar{\'i}a Jos{\'e} Calmuntia and Javier Garc{\'i}a-Frade and Juan Carlos Arroyo Portero and Rosa Aras Lopez and Carmen Lucena Aguilera and Jos{\'e} Alejandro Navajo and Jesus San-Miguel},
  journal={The hematology journal : the official journal of the European Haematology Association},
  year={2004},
  volume={5 6},
  pages={
          480-8
        }
}
The evaluation of bone disease in multiple myeloma (MM) by conventional radiology has low reproducibility. In the last decade, several serum and urine biochemical parameters, for evaluation of bone turnover, have become available. The present study was designed to explore the value of six bone remodelation markers. It was studied in a series of 176 newly diagnosed patients with monoclonal gammopathies (107 MM and 69 monoclonal gammopathies of unknown significance (MGUS)). As control groups we… CONTINUE READING
BETA

Similar Papers

Loading similar papers…